Form 4 for TMO Thermo Fisher Scientific
Accepted 2023-08-02 00:00:00 ET · period of report 2023-07-31 · accession 0001127602-23-021841 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-08-02 | 2023-07-31+ | TMO | Williamson Stephen | SVP, CFO | M - OptEx | $190.59 | +29.1K | 42.4K | +219% | +$5.55M |
| DM | 2023-08-02 | 2023-07-31+ | TMO | Williamson Stephen | SVP, CFO | S - Sale+OE | $553.82 | -29.1K | 27.4K | -52% | -$16.12M |
| DM | 2023-08-02 | 2023-07-31+ | TMO | Williamson Stephen | SVP, CFO | M - OptEx | $0.00 | -29.1K | 14.1K | -67% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-01 | M | A | 14,100 | $190.59 | 41,493 | D | — | — | |
| 2 | Common | Common Stock | 2023-07-31 | S | D | 15,000 | $557.42 | 27,393 | D | — | — | |
| 3 | Common | Common Stock | 2023-07-31 | M | A | 15,000 | $190.59 | 42,393 | D | — | — | |
| 4 | Common | Common Stock | 2023-08-01 | S | D | 14,100 | $550.00 | 27,393 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2023-08-01 | M | D | 14,100 | $0.00 | 0 | D | $190.59 · 2021-03-07 to 2024-09-07 | 14,100 Common Stock | |
| 6 | Derivative | Stock Option (Right to Buy) | 2023-07-31 | M | D | 15,000 | $0.00 | 14,100 | D | $190.59 · 2021-03-07 to 2024-09-07 | 15,000 Common Stock |